Improved survival achieved by HIV-infected patients has complicated their medical care, as increasing numbers of comorbidities have led to polypharmacy and a higher risk of drug–drug interactions. Here, evidence is provided that weight-loss drugs should be used with caution in HIV-infected patients treated with lipophilic antiretroviral drugs because of the risk of virologic failure. This is particularly relevant considering that these agents are available on the market as over-the-counter medications, thus escaping the control of the physician.
Titolo: | Loss of Control of HIV Viremia With OTC Weight-Loss Drugs: A Call for Caution? |
Autori: | GIACOMELLI, ANDREA (Secondo) |
Parole Chiave: | Medicine (miscellaneous); Endocrinology, Diabetes and Metabolism; Endocrinology; Nutrition and Dietetics |
Settore Scientifico Disciplinare: | Settore MED/17 - Malattie Infettive |
Data di pubblicazione: | ago-2018 |
Rivista: | |
Tipologia: | Article (author) |
Digital Object Identifier (DOI): | 10.1002/oby.22240 |
Appare nelle tipologie: | 01 - Articolo su periodico |
File in questo prodotto:
File | Descrizione | Tipologia | Licenza | |
---|---|---|---|---|
Cattaneo_et_al-2018-Obesity (1).pdf | Publisher's version/PDF | Administrator Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.